There's no reason to stop GHK-Cu because of semaglutide-related nausea
2 Other GLP-1 drugs such as Mounjaro, Ozempic, Trulicity, Rybelsus , and Victoza (including a generic version) 3 are approved for the treatment of type 2 diabetes, but not specifically for weight management
Eating smaller, more frequent meals can help with upset stomach, for instance
Preventive measures, including lifestyle modifications, early screenings, and the use of medications to prevent diabetes in prediabetic patients, are becoming more common
, ,
Table 18: Treatment Effects for the Primary Endpoints* and their Components* in the DECLARE Trial Figure 4: Time to First Occurrence of Hospitalization for Heart Failure or CV Death in the DECLARE Trial Figure 5: Time to First Occurrence of Hospitalization for Heart Failure in the DECLARE Trial Chronic Kidney Disease The Trial to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease (DAPA-CKD, NCT03036150) was an international, multicenter, randomized, double-blind, placebo-controlled trial in adult patients with chronic kidney disease (CKD) (eGFR between 25 and 75 mL/min/1.73 m) and albuminuria [urine albumin creatinine ratio (UACR) between 200 and 5000 mg/g] who were receiving standard of care background therapy, including a maximally tolerated, labeled daily dosage of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB)